BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Treatment
355 results:

  • 1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
    Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
    Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
    Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
    Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenetic Modulation of ddit3 and MGMT Expression Acts Synergistically with Resistance to Imatinib towards CML Disease Progression: A Hospital based Study.
    Hazarika G; Kalita MJ; Kalita S; Das PP; Dutta K; Lahkar L; Rajkonwar A; Idris MG; Khamo V; Kusre G; Medhi S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4059-4069. PubMed ID: 38156838
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
    Häselbarth L; Gamali S; Saul D; Krumbholz M; Böttcher-Loschinski R; Böttcher M; Zou D; Metzler M; Karow A; Mougiakakos D
    BMC Cancer; 2023 Nov; 23(1):1153. PubMed ID: 38012567
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SOHO State-of-the-Art Updates and Next Questions: treatment for Newly Diagnosed Peripheral T-Cell Lymphomas.
    Burton JS; Foley NC; Mehta-Shah N
    Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):65-76. PubMed ID: 37973458
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-chop pathway.
    Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
    Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma.
    Roh J; Pak HK; Jeong S; Hwang S; Kim DE; Choi HS; Kim SJ; Kim H; Cho H; Park JS; Jeong SH; Choi YS; Han JH; Yoon DH; Park CS
    Biochem Biophys Res Commun; 2023 Sep; 673():36-43. PubMed ID: 37356143
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Melatonin Can Enhance the Effect of Drugs Used in the treatment of leukemia.
    Lomovsky AI; Baburina YL; Fadeev RS; Lomovskaya YV; Kobyakova MI; Krestinin RR; Sotnikova LD; Krestinina OV
    Biochemistry (Mosc); 2023 Jan; 88(1):73-85. PubMed ID: 37068876
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immune priming with avelumab and rituximab prior to R-chop in diffuse large B-cell lymphoma: the phase II AvR-chop study.
    Manos K; Chong G; Keane C; Lee ST; Smith C; Churilov L; McKendrick J; Renwick W; Blombery P; Burgess M; Nelson NE; Fancourt T; Hawking J; Lin W; Scott AM; Barraclough A; Wight J; Grigg A; Fong CY; Hawkes EA
    Leukemia; 2023 May; 37(5):1092-1102. PubMed ID: 36906715
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multicenter phase 2 study of oral azacitidine (CC-486) plus chop as initial treatment for PTCL.
    Ruan J; Moskowitz A; Mehta-Shah N; Sokol L; Chen Z; Kotlov N; Nos G; Sorokina M; Maksimov V; Sboner A; Sigouros M; van Besien K; Horwitz S; Rutherford SC; Mulvey E; Revuelta MV; Xiang J; Alonso A; Melnick A; Elemento O; Inghirami G; Leonard JP; Cerchietti L; Martin P
    Blood; 2023 May; 141(18):2194-2205. PubMed ID: 36796016
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
    Chiappella A; Dodero A; Evangelista A; Re A; Orsucci L; Usai SV; Castellino C; Stefoni V; Pinto A; Zanni M; Ciancia R; Ghiggi C; Rossi FG; Arcari A; Ilariucci F; Zilioli VR; Flenghi L; Celli M; Volpetti S; Benedetti F; Ballerini F; Musuraca G; Bruna R; Patti C; Leonardi F; Arcaini L; Magagnoli M; Cavallo F; Bermema A; Tucci A; Boccomini C; Ciccone G; Carniti C; Pileri SA; Corradini P
    Leukemia; 2023 Feb; 37(2):433-440. PubMed ID: 36653509
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. treatment of Richter's syndrome.
    Thompson PA; Siddiqi T
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):329-336. PubMed ID: 36485138
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL.
    Lim SK; Peng CC; Low S; Vijay V; Budiman A; Phang BH; Lim JQ; Jeyasekharan AD; Lim ST; Ong CK; Tan SM; Li Y
    Leukemia; 2023 Feb; 37(2):441-452. PubMed ID: 36446947
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.
    He C; Liu B; Wang HY; Wu L; Zhao G; Huang C; Liu Y; Shan B; Liu L
    BMC Cancer; 2022 Oct; 22(1):1100. PubMed ID: 36303126
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 4-Carbomethoxyl-10-Epigyrosanoldie E Extracted from Cultured Soft Coral
    She YY; Lin JJ; Su JH; Chang TS; Wu YJ
    Oxid Med Cell Longev; 2022; 2022():3017807. PubMed ID: 36275891
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MicroRNA-211-5p Overexpression Effect on Endoplasmic Reticulum Stress and Apoptotic Genes in Fibroblast-like Synoviocytes of Rheumatoid Arthritis.
    Farghadan M; Zavaran-Hosseini A; Farhadi E; Sharafat Vaziri A; Tahmasebi MN; Jamshidi A; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):418-428. PubMed ID: 36243930
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial.
    Seifert R; Kersting D; Rischpler C; Sandach P; Ferdinandus J; Fendler WP; Rahbar K; Weckesser M; Umutlu L; Hanoun C; Hüttmann A; Reinhardt HC; von Tresckow B; Herrmann K; Dührsen U; Schäfers M
    Leukemia; 2022 Dec; 36(12):2845-2852. PubMed ID: 36241697
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.